{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001726711","name":"Aditxt, Inc.","summary":"Aditxt, Inc. is a Delaware-incorporated health innovation company headquartered in Mountain View, California. Through subsidiaries Adimune, Inc. and Pearsanta, Inc., it develops immune modulation therapeutics (ADI platform targeting autoimmune diseases and organ transplant rejection) and mitochondrial DNA-based cancer detection tests. Key product candidates include ADI-100 for type-1 diabetes, psoriasis, and Stiff Person Syndrome, plus prostate cancer and endometriosis diagnostic tests based on the Mitomic Technology platform.","people":[],"products":[{"name":"ADI-100","type":"platform","description":"Apoptotic DNA Immunotherapy candidate targeting GAD antigen, designed to induce immune tolerance in type-1 diabetes, psoriasis, and autoimmune CNS diseases."},{"name":"AditxtScore","type":"platform","description":"Immune profiling technology providing personalized comprehensive profiles of the immune system, detecting responses to viruses, bacteria, transplants, and cancer."},{"name":"FlowSpot","type":"platform","description":"Licensed Stanford technology enabling high-throughput immune status assays measuring cellular and humoral immune responses in approximately 3-16 hours."},{"name":"Mitomic Technology Platform","type":"platform","description":"Mitochondrial DNA-based biomarker discovery platform used to develop cancer screening and diagnostic tests for prostate cancer, endometriosis, ovarian, and lung cancer."},{"name":"Prostate Cancer Diagnostic Test","type":"service","description":"In-development mtDNA-based test for prostate cancer diagnosis, requiring further clinical validation."},{"name":"Endometriosis Detection Test","type":"service","description":"In-development mtDNA-based test for detection of endometriosis, requiring further clinical validation."}],"partnerships":[{"partner_name":"Loma Linda University","partnership_type":"licensing","description":"Exclusive royalty-bearing worldwide license for ADI nucleic acid-based immune modulation technology for immune-mediated inflammatory diseases.","start_date":null},{"partner_name":"Leland Stanford Junior University","partnership_type":"licensing","description":"Exclusive worldwide license for FlowSpot patent covering detection and measurement of specific cellular immune responses.","start_date":null},{"partner_name":"Mayo Clinic","partnership_type":"development","description":"Clinical trial agreement signed May 2023 to advance ADI-100 studies targeting autoimmune CNS diseases including Stiff Person Syndrome; also assisting with FDA IND package.","start_date":null},{"partner_name":"MDNA Life Sciences, Inc.","partnership_type":"acquisition","description":"Pearsanta acquired MDNA Life Sciences assets on January 4, 2024, including Mitomic Technology platform and related patents and intellectual property.","start_date":null}],"affiliations":[],"origin":{"leaf":"dbd86d57084f8bf904ff1a8e9642b0c9a65b94ba6c1ca5476d33ee28b627d82e","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"2e3be7ad366fbf572eb8e7ac62aa78fc2ad36a89f5191230aa93b4401af59ee5","parent":"1043de250e56565c4d17c8f93db4aadb6dc6692e508c7ed27dd0035c82736263","source":"0001213900-26-037529","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}